Rosiglitazone delayed weight loss and anorexia while attenuating adipose depletion in mice with cancer cachexia

Cancer Biology and Therapy

Volumn 12, Issue 11, 2011, Pages 957-965

  Asp, Michelle L ^a,b   Tian, Min ^a   Kliewer, Kara L ^a   Belury, Martha A ^a  

^a OHIO STATE UNIVERSITY   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Cancer cachexia; Colon 26 adenocarcinoma; Insulin resistance; Rosiglitazone

Indexed keywords

MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR DELTA; PYRUVATE DEHYDROGENASE KINASE 4; ROSIGLITAZONE;

ADIPOCYTE; ADIPOSE DEPLETION; ADIPOSE TISSUE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANOREXIA; ARTICLE; ATTENUATION; CACHEXIA; CANCER CACHEXIA; CONTROLLED STUDY; DEPLETION; FOOD INTAKE; MALE; MOUSE; MUSCLE MASS; NONHUMAN; OBESITY; PROTEIN DEGRADATION; QUADRICEPS FEMORIS MUSCLE; WEIGHT REDUCTION;

ADIPOSE TISSUE; ANIMALS; ANOREXIA; BLOOD GLUCOSE; CACHEXIA; EATING; HUMANS; HYPOGLYCEMIC AGENTS; INFLAMMATION; INSULIN RESISTANCE; MICE; MUSCLE STRENGTH; NEOPLASMS; ORGAN SIZE; PROTEOLYSIS; THIAZOLIDINEDIONES; WEIGHT LOSS;

EID: 82755195290     PISSN: 15384047     EISSN: 15558576     Source Type: Journal    
DOI: 10.4161/cbt.12.11.18134     Document Type: Article

References (33)

1. Muscaritoli M, Anker SD, Argilés J, Aversa Z, Bauer JM, Biolo G, et al. Consensus definition of sarcopenia, cachexia and pre-cachexia: joint document elaborated by Special Interest Groups (SIG) "cachexia-anorexia in chronic wasting diseases" and "nutrition in geriatrics". Clin Nutr 2010; 29:154-9; PMID:20060626; http://dx.doi.org/10.1016/j.clnu.2009.12.004
2. Argilés JM, Almendro V, Busquets S, Lopez-Soriano FJ. The pharmacological treatment of cachexia. Curr Drug Targets 2004; 5:265-77; PMID:15058312; http://dx.doi.org/10.2174/1389450043490505
3. Dewys WD, Begg C, Lavin PT, Band PR, Bennett JM, Bertino JR, et al. Prognostic effect of weight loss prior to chemotherapy in cancer patients. Am J Med 1980;69:491-7; PMID:7424938; http://dx.doi.org/10.1016/ S0149-2918(05)80001- 3
4. Warren S. The immediate causes of death in cancer. Am J Med Sci 1932; 184:610-5; http://dx.doi.org/10.1097/00000441-193211000-00002
5. Inagaki J, Rodriguez V, Bodey GP. Causes of death in cancer patients. Cancer 1974; 33:568-73; PMID: 4591273; http://dx.doi.org/10.1002/1097-0142 (197402)33:2,568::AID-CNCR2820330236.3.0. CO;2-2
6. Argilés JM. López-Soriano, Busquets S. Novel approaches to the treatment of cachexia. Drug Discov Today 2008; 13:73-8; PMID:18190867; http://dx.doi.org/10.1016/j.drudis.2007.10.008
7. Bozzetti F, Ammatuna M, Migliavacca S, Bonalumi MG, Facchetti G, Pupa A, et al. Total parenteral nutrition prevents further nutritional deterioration in patients with cancer cachexia. Ann Surg 1987; 205: 138-43; PMID:3101624; http://dx.doi.org/10.1097/00000658-198702000-00007
8. Rohdenburg GL, Bernhard A, Krehbiel O. Sugar tolerance in cancer. J Am Med Assoc 1919; 72:528-30.
9. Moley JF, Morrison SD, Norton JA. Preoperative insulin reverses cachexia and decreases mortality in tumor-bearing rats. J Surg Res 1987; 43:21-8; PMID: 3599982; http://dx.doi.org/10.1016/0022-4804(87) 90042-4
10. Moley JF, Morrison SD, Gorschboth CM, Norton JA. Body composition changes in rats with experimental cancer cachexia: improvement with exogenous insulin. Cancer Res 1988; 48:2784-7; PMID:3282649
11. Peacock JL, Norton JA. Impact of insulin on survival of cachectic tumor bearing rats. JPEN J Parenter Enteral Nutr 1988; 12:260-4; PMID:3392822; http://dx.doi.org/10.1177/0148607188012003260
12. Beck SA, Tisdale MJ. Effect of insulin on weight loss and tumour growth in a cachexia model. Br J Cancer 1989; 59:677-81; PMID:2736199; http://dx.doi.org/10.1038/bjc.1989.140
13. Pearlstone DB, Wolf RF, Berman RS, Burt M, Brennan MF. Effect of systemic insulin on protein kinetics in postoperative cancer patients. Ann Surg Oncol 1994; 1:321-32; PMID:7850531; http://dx.doi.org/10.1007/BF02303571
14. Lundholm K, Körner U, Gunnebo L, Sixt-Ammilon P, Fouladiun M, Daneryd P, et al. Insulin treatment in cancer cachexia: effects on survival, metabolism and physical functioning. Clin Cancer Res 2007; 13:2699-706; PMID:17473202; http://dx.doi.org/10.1158/ 1078-0432.CCR-06-2720
15. Cersosimo E, Pisters PW, Pesola G, Rogatko A, Vydelingum NA, Bajorunas D, et al. The effect of graded doses of insulin on peripheral glucose uptake and lactate release in cancer cachexia. Surgery 1991;109:459-67; PMID:2008651
16. Dodesini AR, Benedini S, Terruzzi I, Sereni LP, Luzi L. Protein, glucose and lipid metabolism in the cancer cachexia: A preliminary report. Acta Oncol 2007; 46: 118-20; PMID:17438714; http://dx.doi.org/10.1080/02841860600791491
17. Asp ML, Tian M, Wendel AA, Belury MA. Evidence for the contribution of insulin resistance to the development of cachexia in tumor-bearing mice. Int J Cancer 2010; 126:756-63; PMID:19634137; http://dx.doi.org/10.1002/ijc.24784
18. Schenk S, Saberi M, Olefsky JM. Insulin sensitivity: modulation by nutrients and inflammation. J Clin Invest 2008; 118:2992-3002; PMID:18769626; http://dx.doi.org/10.1172/JCI34260
19. Hauner H. The mode of action of thiazolidinediones. Diabetes Metab Res Rev 2002; 18:S10-5; PMID: 11921433; http://dx.doi.org/10.1002/dmrr.249
20. Tisdale MJ. Mechanisms of cancer cachexia. Physiol Rev 2009; 89:381-410; PMID:19342610; http://dx.doi.org/10.1152/physrev.00016.2008
21. Wang X, Hu Z, Hu J, Du J, Mitch WE. Insulin resistance accelerates muscle protein degradation: activation of the ubiquitin-proteasome pathway by defects in muscle cell signaling. Endocrinology 2006; 147: 4160-8; PMID:16777975; http://dx.doi.org/10.1210/ en.2006-0251
22. Evans WJ, Morley JE, Argilés J, Bales C, Baracos V, Guttridge D, et al. Cachexia: a new definition. Clin Nutr 2008; 27:793-9; PMID:18718696; http://dx.doi. org/10.1016/j.clnu.2008.06.013
23. Gomes MD, Lecker SH, Jagoe RT, Navon A, Goldberg AL. Atrogin-1, a muscle specific F-box protein highly expressed during muscle atrophy. Proc Natl Acad Sci USA 2001; 98:14440-5; PMID:11717410; http://dx.doi.org/10.1073/pnas. 251541198
24. Bodine SC, Latres E, Baumhueter S, Lai VKM, Nunez L, Clarke BA, et al. Identification of ubiquitin ligases required for skeletal muscle atrophy. Science 2001; 294:1704-8; PMID:11679633; http://dx.doi.org/10.1126/science. 1065874
25. Mammucari C, Milan G, Romanello V, Masiero E, Rudolf R, Del Piccolo P, et al. FoxO3 controls autophagy in skeletal muscle in vivo. Cell Metab 2007; 6:458-71; PMID:18054315; http://dx.doi.org/10.1016/j.cmet.2007.11.001
26. Strassmann G, Fong M, Kenney JS, Jacob CO. Evidence for the involvement of interleukin 6 in experimental cancer cachexia. J Clin Invest 1992; 89:1681-4; PMID:1569207; http://dx.doi.org/10.1172/JCI115767
27. de Lange P, Moreno M, Silvestri E, Lombardi A, Goglia F, Lanni A. Fuel economy in food-deprived skeletal muscle: signaling pathways and regulatory mechanisms. FASEB J 2007; 21:3431-41; PMID: 17595346; http://dx.doi.org/10.1096/ fj.07-8527rev
28. Pecqueur C, Bui T, Gelly C, Hauchard J, Barbot C, Bouillaud F, et al. Uncoupling protein-2 controls proliferation by promoting fatty acid oxidation and limiting glycolysis-derived pyruvate utilization. FASEB J 2008; 22:9-18; PMID:17855623; http://dx.doi.org/10.1096/fj.07-8945com
29. Tian M, Kliewer KL, Asp ML, Sout MB, Belury MA. c9t11-Conjugated linoleic acid-rich oil fails to attenuate wasting in colon-26 tumor-induced late-stage cancer cachexia in male CD2F1 mice. Mol Nutr Food Res 2011; 55:268-77; PMID:20827675; http://dx.doi.org/10.1002/mnfr.201000176
30. Lehrke M, Lazar MA. The many faces of PPARgamma. Cell 2005; 123:993-9; PMID:16360030; http://dx.doi.org/10.1016/j.cell.2005.11.026
31. Guerre-Millo M. Adiponectin: an update. Diabetes Metab 2008; 34:12-8; PMID:18069030
32. Acharyya S, Ladner KJ, Nelsen LL, Damrauer J, Reiser PJ, Swoap S, et al. Cancer cachexia is regulated by selective targeting of skeletal muscle gene products. J Clin Invest 2004; 114:370-8; PMID:15286803
33. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real time quantitative PCR and the 2(-Delta Delta C(T)). Methods 2001; 25:402-8; PMID:11846609; http://dx.doi.org/10.1006/meth. 2001.1262